About United Therapeutics Corporation
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.
2BB score and signals
United Therapeutics Corporation’s current 2BB score is 59 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 67 | High |
| Momentum | 49 | Stable |
| Financial strength | 89 | Very Strong |
| Quality | 100 | Very Strong |
| Risk | 30 | Low |
Company facts
| Headquarters | Silver Spring, Maryland, United States |
| Founded | 1996 |
| Employees | 1.4K |
| P/E ratio | 18.88 |
| 52-week range | $302.19 – $609.35 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-23 | — | 6.9278 | — | $818.52M |
| 2026-10-27 | — | 6.5587 | — | $806.68M |
| 2026-08-05 | — | 6.969 | — | $821.76M |
| 2026-05-06 | 5.82 | 7.0057 | $781.50M | $812.86M |
Related companies
